Trial Profile
Evaluation of the effect of agomelatine and escitalopram on emotions and motivation in healthy male and female volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Dec 2017
Price :
$35
*
At a glance
- Drugs Agomelatine (Primary) ; Escitalopram
- Indications Anxiety disorders; Major depressive disorder
- Focus Pharmacodynamics
- Sponsors IRIS
- 31 May 2013 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 08 Aug 2011 New trial record